TAFENOQUINE

TAFENOQUINE was reported 66 times

TAFENOQUINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLASMODIUM VIVAX INFECTION 2 0.0870
1 MANGANESE INCREASED 1 0.0833
2 CYP2D6 POLYMORPHISM 2 0.0455
3 STRUCK BY LIGHTNING 1 0.0286
4 THYROID GLAND INJURY 1 0.0200
5 BLOOD METHAEMOGLOBIN PRESENT 2 0.0180
6 FEAR OF CROWDED PLACES 1 0.0149
7 VIIITH NERVE INJURY 1 0.0147
8 ANTISOCIAL PERSONALITY DISORDER 1 0.0078
9 NEUROPSYCHIATRIC SYNDROME 1 0.0045
10 MALARIA 3 0.0043
11 CHEYNE-STOKES RESPIRATION 1 0.0040
12 STIFF PERSON SYNDROME 1 0.0029
13 CAT SCRATCH DISEASE 1 0.0025
14 OROPHARYNGEAL SPASM 1 0.0024
15 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
16 ADJUSTMENT DISORDER 3 0.0023
17 POST-TRAUMATIC STRESS DISORDER 15 0.0022
18 NEUROPSYCHIATRIC SYMPTOMS 2 0.0022
19 ABULIA 2 0.0022
20 AUDITORY DISORDER 3 0.0021
21 PARTNER STRESS 2 0.0021
22 HYPERVIGILANCE 2 0.0021
23 VERBAL ABUSE 1 0.0020
24 INTRAVASCULAR HAEMOLYSIS 1 0.0018
25 METHAEMOGLOBINAEMIA 4 0.0017
26 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
27 ALCOHOL ABUSE 4 0.0015
28 DISSOCIATIVE DISORDER 1 0.0014
29 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
30 CYCLIC VOMITING SYNDROME 1 0.0014
31 PHYSICAL ASSAULT 2 0.0010
32 BRAIN INJURY 9 0.0009
33 STRESS AT WORK 1 0.0009
34 INTRUSIVE THOUGHTS 1 0.0008
35 VESTIBULAR DISORDER 1 0.0008
36 LIP DISCOLOURATION 1 0.0008
37 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
38 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
39 MENTAL FATIGUE 1 0.0007
40 HYPOSMIA 1 0.0007
41 ILLUSION 1 0.0006
42 MILIARIA 1 0.0006
43 PARANOIA 10 0.0006
44 EMOTIONAL POVERTY 1 0.0006
45 HANGOVER 2 0.0006
46 MAJOR DEPRESSION 4 0.0005
47 NARCOLEPSY 1 0.0005
48 ADRENAL DISORDER 1 0.0005
49 CONCOMITANT DISEASE PROGRESSION 1 0.0005
50 FRUSTRATION TOLERANCE DECREASED 4 0.0005
51 PSYCHOTIC SYMPTOM 1 0.0005
52 SCREAMING 3 0.0005
53 DENGUE FEVER 1 0.0004
54 PERFORMANCE STATUS DECREASED 2 0.0004
55 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
56 ANGER 14 0.0004
57 PSYCHIATRIC SYMPTOM 3 0.0004
58 PRODUCT ODOUR ABNORMAL 4 0.0004
59 BIPOLAR DISORDER 4 0.0004
60 NEGATIVE THOUGHTS 1 0.0003
61 DRUG RESISTANCE 8 0.0003
62 TACHYPHRENIA 1 0.0003
63 MOOD SWINGS 9 0.0003
64 IRRITABLE BOWEL SYNDROME 6 0.0003
65 HYPERACUSIS 1 0.0003
66 IMPULSIVE BEHAVIOUR 1 0.0003
67 PROTEIN TOTAL DECREASED 1 0.0003
68 TINNITUS 12 0.0003
69 NIGHTMARE 9 0.0003
70 HOMICIDAL IDEATION 1 0.0002
71 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
72 POOR QUALITY SLEEP 5 0.0002
73 OCULAR ICTERUS 1 0.0002
74 MENTAL DISORDER 10 0.0002
75 DEAFNESS 6 0.0002
76 DYSPHEMIA 1 0.0002
77 RENAL FUNCTION TEST ABNORMAL 1 0.0002
78 PERSONALITY CHANGE 2 0.0002
79 FEELING OF DESPAIR 1 0.0002
80 AUTOIMMUNE DISORDER 2 0.0002
81 VITREOUS FLOATERS 2 0.0002
82 FOOD POISONING 1 0.0002
83 ABNORMAL DREAMS 5 0.0002
84 ABNORMAL BEHAVIOUR 7 0.0002
85 METABOLIC DISORDER 1 0.0002
86 NEUROTOXICITY 3 0.0002
87 SUICIDE ATTEMPT 10 0.0002
88 SCHIZOPHRENIA 2 0.0002
89 PRE-EXISTING CONDITION IMPROVED 1 0.0002
90 POISONING 2 0.0002
91 BRAIN OEDEMA 2 0.0002
92 INCOHERENT 1 0.0002
93 DEPRESSED MOOD 8 0.0002
94 DISTURBANCE IN ATTENTION 8 0.0001
95 PANIC REACTION 1 0.0001
96 APNOEA 1 0.0001
97 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
98 BLOOD ALBUMIN DECREASED 1 0.0001
99 MENTAL IMPAIRMENT 3 0.0001
100 AMNESIA 8 0.0001
101 PHOTOSENSITIVITY REACTION 2 0.0001
102 AGGRESSION 6 0.0001
103 COLD SWEAT 2 0.0001
104 HAEMOLYTIC ANAEMIA 1 0.0001
105 ANAL INCONTINENCE 1 0.0001
106 MOOD ALTERED 3 0.0001
107 PATHOGEN RESISTANCE 1 0.0001
108 MIDDLE INSOMNIA 2 0.0001
109 DYSPNOEA EXERTIONAL 4 0.0001
110 ILL-DEFINED DISORDER 6 0.0001
111 SUICIDAL IDEATION 9 0.0001
112 INITIAL INSOMNIA 1 0.0001
113 INCONTINENCE 1 0.0001
114 JOINT DISLOCATION 1 0.0001
115 IMPAIRED WORK ABILITY 2 0.0001
116 BLOOD CALCIUM DECREASED 1 0.0001
117 DEPRESSION 20 0.0001
118 COGNITIVE DISORDER 4 0.0001
119 VERTIGO 5 0.0001
120 ENCEPHALOPATHY 2 0.0001
121 ANOREXIA 1 0.0001
122 EYE HAEMORRHAGE 1 0.0001
123 PRODUCT TASTE ABNORMAL 1 0.0001
124 IMPAIRED GASTRIC EMPTYING 1 0.0001
125 MEMORY IMPAIRMENT 10 0.0001
126 COORDINATION ABNORMAL 1 0.0001
127 MASS 1 0.0001
128 SLEEP DISORDER 5 0.0001
129 IMPAIRED QUALITY OF LIFE 1 0.0001
130 GASTROENTERITIS 1 0.0001
131 THYROID DISORDER 1 0.0001
132 CYANOSIS 1 0.0001
133 PRODUCT USE COMPLAINT 1 0.0001
134 ANXIETY 18 0.0001
135 DISEASE RECURRENCE 3 0.0001
136 COMA 3 0.0001
137 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
138 NIGHT SWEATS 2 0.0001
139 MUSCLE TIGHTNESS 1 0.0001
140 BALANCE DISORDER 5 0.0001
141 SPEECH DISORDER 3 0.0001
142 HEAD DISCOMFORT 1 0.0001
143 CRYING 2 0.0001
144 RESTLESSNESS 2 0.0001
145 AGITATION 4 0.0001
146 THINKING ABNORMAL 1 0.0001
147 PHOTOPHOBIA 1 0.0001
148 HALLUCINATION 4 0.0001
149 FRACTURE 1 0.0001
150 GASTRIC ULCER 1 0.0001
151 INCREASED APPETITE 1 0.0001
152 DISABILITY 1 0.0001
153 HAEMATOCRIT DECREASED 1 0.0001
154 ABDOMINAL DISCOMFORT 8 0.0000
155 JOINT INJURY 1 0.0000
156 PRODUCT PRESCRIBING ISSUE 1 0.0000
157 CHROMATURIA 1 0.0000
158 NEPHROLITHIASIS 2 0.0000
159 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
160 UNRESPONSIVE TO STIMULI 1 0.0000
161 RASH GENERALISED 1 0.0000
162 JAUNDICE 1 0.0000
163 PALLOR 1 0.0000
164 COMPLETED SUICIDE 3 0.0000
165 FEELING COLD 1 0.0000
166 LIVER FUNCTION TEST ABNORMAL 1 0.0000
167 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
168 PSYCHOTIC DISORDER 1 0.0000
169 RESPIRATORY DISORDER 1 0.0000
170 ADVERSE DRUG REACTION 3 0.0000
171 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
172 EMOTIONAL DISORDER 1 0.0000
173 NERVOUS SYSTEM DISORDER 1 0.0000
174 HYPOXIA 1 0.0000
175 CEREBRAL HAEMORRHAGE 1 0.0000
176 HYPERGLYCAEMIA 1 0.0000
177 PANIC ATTACK 1 0.0000
178 UNEVALUABLE EVENT 2 0.0000
179 SEIZURE 3 0.0000
180 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
181 EMOTIONAL DISTRESS 3 0.0000
182 EXTRA DOSE ADMINISTERED 1 0.0000
183 DYSKINESIA 1 0.0000
184 BLINDNESS 1 0.0000
185 CARDIAC ARREST 2 0.0000
186 TREMOR 4 0.0000
187 RHABDOMYOLYSIS 1 0.0000
188 TOXICITY TO VARIOUS AGENTS 4 0.0000
189 LOSS OF CONSCIOUSNESS 3 0.0000
190 HYPERHIDROSIS 3 0.0000
191 INSOMNIA 6 0.0000
192 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
193 MIGRAINE 2 0.0000
194 MULTIPLE SCLEROSIS 1 0.0000
195 FEELING ABNORMAL 5 0.0000
196 INFECTION 3 0.0000
197 DIZZINESS 10 0.0000
198 CONDITION AGGRAVATED 6 0.0000
199 NAUSEA 15 0.0000
200 PANCREATITIS 1 0.0000
201 CONFUSIONAL STATE 3 0.0000
202 TREATMENT NONCOMPLIANCE 1 0.0000
203 OXYGEN SATURATION DECREASED 1 0.0000
204 HEADACHE 11 0.0000
205 DECREASED APPETITE 4 0.0000
206 PALPITATIONS 2 0.0000
207 VOMITING 8 0.0000
208 IRRITABILITY 1 0.0000
209 MUSCLE SPASMS 3 0.0000
210 VISUAL IMPAIRMENT 2 0.0000
211 MALAISE 7 0.0000
212 ASTHENIA 6 0.0000
213 DEHYDRATION 2 0.0000
214 INJURY 1 0.0000
215 OVERDOSE 3 0.0000
216 DYSGEUSIA 1 0.0000
217 DIABETES MELLITUS 1 0.0000
218 DIARRHOEA 8 0.0000
219 TREATMENT FAILURE 1 0.0000
220 OFF LABEL USE 10 0.0000
221 GASTROINTESTINAL DISORDER 1 0.0000
222 SWELLING 1 0.0000
223 PRODUCT USE ISSUE 2 0.0000
224 DRUG INTOLERANCE 1 0.0000
225 HEART RATE INCREASED 1 0.0000
226 SYNCOPE 1 0.0000
227 SOMNOLENCE 2 0.0000
228 HAEMOGLOBIN DECREASED 1 0.0000
229 ABDOMINAL PAIN UPPER 2 0.0000
230 ILLNESS 1 0.0000
231 HYPERTENSION 2 0.0000
232 THROMBOCYTOPENIA 1 0.0000
233 MUSCULAR WEAKNESS 1 0.0000
234 FATIGUE 6 0.0000
235 NEUTROPENIA 1 0.0000
236 VISION BLURRED 1 0.0000
237 RASH 3 0.0000
238 BLOOD PRESSURE INCREASED 1 0.0000
239 ACUTE KIDNEY INJURY 1 0.0000
240 DRUG INEFFECTIVE 8 0.0000
241 CEREBROVASCULAR ACCIDENT 1 0.0000
242 MYALGIA 1 0.0000
243 CHEST PAIN 1 0.0000
244 ANAEMIA 1 0.0000
245 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
246 CONSTIPATION 1 0.0000
247 BACK PAIN 1 0.0000
248 ABDOMINAL PAIN 1 0.0000
249 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
250 WEIGHT DECREASED 1 0.0000
251 PRODUCT DOSE OMISSION ISSUE 1 0.0000
252 FALL 1 0.0000
253 PYREXIA 1 0.0000
254 DYSPNOEA 1 0.0000
255 PAIN 1 0.0000
256 DEATH 1 0.0000